Annovis Bio, Inc. (ANVS)
0.9934
-0.06
(-5.39%)
USD |
NYSE |
Oct 16, 16:00
1.00
+0.01
(+0.66%)
Pre-Market: 20:00
Annovis Bio Price : 0.9934 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.06 | 1.08 | 0.987 | 0.9934 | 641423.0 |
| Oct 15, 2026 | 1.04 | 1.075 | 1.01 | 1.05 | 572216.0 |
| Oct 14, 2026 | 1.05 | 1.08 | 1.01 | 1.02 | 850261.0 |
| Oct 13, 2026 | 1.15 | 1.15 | 1.05 | 1.06 | 851014.0 |
| Oct 12, 2026 | 1.21 | 1.21 | 1.14 | 1.15 | 460230.0 |
| Oct 09, 2026 | 1.17 | 1.24 | 1.14 | 1.21 | 521897.0 |
| Oct 08, 2026 | 1.21 | 1.21 | 1.14 | 1.17 | 815380.0 |
| Oct 07, 2026 | 1.17 | 1.23 | 1.16 | 1.21 | 430012.0 |
| Oct 06, 2026 | 1.20 | 1.24 | 1.17 | 1.18 | 538719.0 |
| Oct 05, 2026 | 1.16 | 1.20 | 1.135 | 1.20 | 657640.0 |
| Oct 02, 2026 | 1.19 | 1.196 | 1.135 | 1.18 | 648539.0 |
| Oct 01, 2026 | 1.27 | 1.28 | 1.16 | 1.17 | 1.202M |
| Sep 30, 2026 | 1.30 | 1.335 | 1.27 | 1.27 | 572995.0 |
| Sep 29, 2026 | 1.39 | 1.41 | 1.30 | 1.30 | 812053.0 |
| Sep 28, 2026 | 1.32 | 1.43 | 1.30 | 1.38 | 1.199M |
| Sep 25, 2026 | 1.35 | 1.36 | 1.305 | 1.31 | 573617.0 |
| Sep 24, 2026 | 1.27 | 1.34 | 1.23 | 1.33 | 855174.0 |
| Sep 23, 2026 | 1.30 | 1.33 | 1.235 | 1.27 | 1.146M |
| Sep 22, 2026 | 1.19 | 1.30 | 1.185 | 1.26 | 1.215M |
| Sep 21, 2026 | 1.16 | 1.22 | 1.16 | 1.19 | 885902.0 |
| Sep 18, 2026 | 1.12 | 1.16 | 1.09 | 1.14 | 681977.0 |
| Sep 17, 2026 | 1.10 | 1.17 | 1.08 | 1.10 | 1.523M |
| Sep 16, 2026 | 1.12 | 1.13 | 1.04 | 1.04 | 1.433M |
| Sep 15, 2026 | 1.14 | 1.14 | 1.10 | 1.12 | 824332.0 |
| Sep 14, 2026 | 1.10 | 1.17 | 1.095 | 1.14 | 1.202M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.12 |
| Alnylam Pharmaceuticals, Inc. | 231.83 |
| Anika Therapeutics, Inc. | 19.98 |
| Savara, Inc. | 4.45 |
| Vericel Corp. | 40.13 |
Price Related Metrics
| Earnings Yield | -180.4% |
| Market Cap | 42.32M |